Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

2006-05-01

Journal of Clinical Oncology , Volume 24 - Issue 13 p. 20- 22

Additional Metadata
Keywords	*Adoptive Transfer, Antibodies, Monoclonal/ genetics, Antigens, Neoplasm/ immunology, Carbonic Anhydrases/ immunology, Carcinoma, Renal Cell/enzymology/pathology/ therapy, Humans, Immunoglobulin Fragments/ genetics, Kidney Neoplasms/enzymology/pathology/ therapy, Neoplasm Metastasis, T-Lymphocytes/ metabolism
Persistent URL	doi.org/10.1200/JCO.2006.05.9964, hdl.handle.net/1765/21392
Journal	Journal of Clinical Oncology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Lamers, C., Sleijfer, S., Vulto, A., Kruit, W., Kliffen, M., Debets, R., … Stoter, G. (2006). Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. Journal of Clinical Oncology, 24(13), 20–22. doi:10.1200/JCO.2006.05.9964

Publication